Article
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
Endocrine-related cancer - 1 Oct 2013
Jaffrain-Rea Marie-Lise, Rotondi Sandra, Turchi Annarita, Occhi Gianluca, Barlier Anne, Peverelli Erika, Rostomyan Lilya, Defilles Céline, Angelini Mariolina, Oliva Maria-Antonietta, Ceccato Filippo, Maiorani Orlando, Daly Adrian F, Esposito Vincenzo, Buttarelli Francesca, Figarella-Branger Dominique, Giangaspero Felice, Spada Anna, Scaroni Carla, Alesse Edoardo, Beckers Albert
Abstract excerpt
Germline aryl hydrocarbon receptor interacting protein (AIP) gene mutations confer a predisposition to pituitary adenoma (PA), predominantly GH-secreting (GH-PA). As recent data suggest a role for AIP in the pathogenesis of sporadic GH-PA and their response to somatostatin analogues (SSA), the expression of AIP and its partner, aryl hydrocarbon receptor (AHR), was determined by semiquantitative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
